Castle Biosciences menaikkan panduan pendapatan 2026 menjadi $365 juta-$375 juta seiring tren volume TissueCypher menuju pertumbuhan 50%-52% (NASDAQ:CSTL)
· seekingalpha.com
Rekap laporan laba Q2 2026 Castle Biosciences (CSTL): pendapatan naik 20%, panduan dinaikkan, lonjakan TissueCypher, serta risiko margin/ASP.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...